Video

Dr Melinda Magyari Addresses the Use of Disease-Modifying MS Therapies in Children

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, addresses the current state of knowledge on using disease-modifying therapies to treat children with multiple sclerosis (MS).

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, addresses the current state of knowledge on using disease-modifying therapies to treat children with multiple sclerosis (MS).

Transcript

What is the current understanding about how to use disease-modifying therapies in children and adolescents with MS?

We don’t know a lot about it. This was my question looking at my own registry. I haven't really seen many similar studies published from other countries to see whether those not-existing guidelines has been interpreted the same way as we did in Denmark. So it would, I would encourage everybody having a cohort registry to publish these data.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Pankit Vachhani
Mansi Shah, MD
Dr John Mascarenhas
2 experts in this video
2 experts in this video
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Dr John Mascarenhas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo